US Stock MarketDetailed Quotes
CRBP Corbus Pharmaceuticals
- 18.4100
- -0.2200-1.18%
Close Oct 18 16:00 ET
- 18.5800
- +0.1700+0.92%
Post 20:02 ET
221.73MMarket Cap-3179P/E (TTM)
19.3200High18.3700Low409.59KVolume18.6900Open18.6300Pre Close7.66MTurnover4.90%Turnover RatioLossP/E (Static)12.04MShares61.900052wk High1.77P/B153.76MFloat Cap3.033452wk Low--Dividend TTM8.35MShs Float323.4000Historical High--Div YieldTTM5.10%Amplitude2.1100Historical Low18.7000Avg Price1Lot Size
Corbus Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 34.18%10.99M | -44.37%9.62M | 29.40%45.08M | -6.42%10.1M | 15.97%9.49M | 11.57%8.19M | 103.08%17.3M | -38.75%34.84M | 7.99%10.8M | -41.45%8.18M |
| Selling and administrative expenses | 4.64%4.12M | -1.21%3.86M | -25.61%13.91M | -31.42%3.12M | -27.88%2.94M | -18.60%3.94M | -25.28%3.91M | -8.45%18.7M | 7.54%4.55M | -22.81%4.07M |
| -General and administrative expense | 4.64%4.12M | -1.21%3.86M | -25.61%13.91M | -31.42%3.12M | -27.88%2.94M | -18.60%3.94M | -25.28%3.91M | -8.45%18.7M | 7.54%4.55M | -22.81%4.07M |
| Research and development costs | 61.57%6.87M | -56.97%5.76M | 93.15%31.17M | 11.81%6.98M | 59.45%6.55M | 69.98%4.25M | 307.41%13.39M | -55.72%16.14M | 8.31%6.24M | -52.76%4.11M |
| Operating profit | -34.18%-10.99M | 44.37%-9.62M | -29.40%-45.08M | 6.42%-10.1M | -15.97%-9.49M | -11.57%-8.19M | -103.08%-17.3M | 37.78%-34.84M | -7.99%-10.8M | 41.04%-8.18M |
| Net non-operating interest income expense | 132.73%254K | 73.89%-177.02K | -37.14%-2.92M | -10.31%-707.01K | -40.87%-763.36K | -58.26%-776K | -47.75%-678.02K | -16.48%-2.13M | -63.97%-640.95K | -38.28%-541.89K |
| Non-operating interest income | 290.52%906K | ---- | ---- | ---- | ---- | --232K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -35.32%652K | ---- | ---- | ---- | 40.87%763.36K | --1.01M | ---- | ---- | ---- | --541.89K |
| Total other finance cost | ---- | -73.89%177.02K | 37.14%2.92M | ---- | ---- | ---- | 47.75%678.02K | 16.48%2.13M | ---- | ---- |
| Other net income (expense) | 307.18%737K | 1,160.01%2.9M | 163.17%3.4M | 399.17%2.79M | 439.23%198.03K | 103.34%181K | 149.92%230.24K | -144.17%-5.38M | 334.71%558.72K | -100.48%-58.38K |
| Gain on sale of security | 2,200.00%42K | -1,213.74%-8.11K | 102.58%8.52K | -89.68%29.23K | 85.66%-19.52K | 99.05%-2K | 100.27%728 | -218.45%-330.59K | 1,401.20%283.17K | -334.25%-136.09K |
| Special income (charges) | ---- | ---- | --0 | --0 | --0 | ---- | ---- | ---5M | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5M | --0 | ---- |
| Other non- operating income (expenses) | 279.78%695K | 1,167.54%2.91M | 7,049.42%3.39M | 901.54%2.76M | 179.94%217.55K | 187.69%183K | 218.70%229.51K | -100.41%-48.77K | 151.27%275.55K | -99.35%77.71K |
| Income before tax | -13.81%-10M | 61.12%-6.9M | -5.33%-44.6M | 26.27%-8.02M | -14.48%-10.05M | 33.70%-8.78M | -88.03%-17.74M | 7.22%-42.35M | -6.03%-10.88M | -303.54%-8.78M |
| Income tax | ||||||||||
| Net income | -13.81%-10M | 61.12%-6.9M | -5.33%-44.6M | 26.27%-8.02M | -14.48%-10.05M | 33.70%-8.78M | -88.03%-17.74M | 7.22%-42.35M | -6.03%-10.88M | -303.54%-8.78M |
| Net income continuous Operations | -13.81%-10M | 61.12%-6.9M | -5.33%-44.6M | 26.27%-8.02M | -14.48%-10.05M | 33.70%-8.78M | -88.03%-17.74M | 7.22%-42.35M | -6.03%-10.88M | -303.54%-8.78M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -13.81%-10M | 61.12%-6.9M | -5.33%-44.6M | 26.27%-8.02M | -14.48%-10.05M | 33.70%-8.78M | -88.03%-17.74M | 7.22%-42.35M | -6.03%-10.88M | -303.54%-8.78M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -13.81%-10M | 61.12%-6.9M | -5.33%-44.6M | 26.27%-8.02M | -14.48%-10.05M | 33.70%-8.78M | -88.03%-17.74M | 7.22%-42.35M | -6.03%-10.88M | -303.54%-8.78M |
| Basic earnings per share | 56.10%-0.9 | 80.42%-0.83 | -1.58%-10.31 | 31.42%-1.79 | -7.58%-2.27 | 35.53%-2.05 | -87.61%-4.24 | 8.97%-10.15 | -8.75%-2.61 | -251.67%-2.11 |
| Diluted earnings per share | 56.10%-0.9 | 80.42%-0.83 | -1.58%-10.31 | 31.42%-1.79 | -7.58%-2.27 | 35.53%-2.05 | -87.61%-4.24 | 8.97%-10.15 | -8.75%-2.61 | -251.67%-2.11 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data